Clinical Features	Time to Death		AGE		GENDER		KARNOFSKY.PERFORMANCE.SCORE		PATHOLOGY.T		PATHOLOGY.N		PATHOLOGICSPREAD(M)		TUMOR.STAGE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q
MET	7 (7%)	91	0.68969	1	0.88664	1	1	1	NA	NA	1	1	NA	NA	0.80634	1	0.89385	1
IL32	4 (4%)	94	1.5765e-14	1.21e-12	0.36193	1	0.30427	1	NA	NA	0.78027	1	NA	NA	0.22263	1	0.67596	1
NF2	5 (5%)	93	0.60311	1	0.29942	1	1	1	NA	NA	0.40415	1	NA	NA	0.03169	1	0.091067	1
LGI4	4 (4%)	94	0.18938	1	0.9053	1	0.30427	1	NA	NA	0.78027	1	NA	NA	0.70257	1	0.67596	1
PCF11	7 (7%)	91	0.82789	1	0.40329	1	0.42635	1	NA	NA	0.86394	1	0.20397	1	0.58448	1	1	1
PARD6B	4 (4%)	94	0.41913	1	0.74038	1	0.30427	1	NA	NA	0.17273	1	NA	NA	1	1	0.571	1
CHCHD3	3 (3%)	95	0.99668	1	0.75718	1	0.54936	1	NA	NA	1	1	NA	NA	1	1	1	1
KDM6A	5 (5%)	93	NA	NA	0.70856	1	1	1	NA	NA	0.52957	1	NA	NA	0.73756	1	0.86811	1
POMC	3 (3%)	95	0.37139	1	0.43977	1	1	1	NA	NA	0.22341	1	NA	NA	0.40683	1	0.25849	1
SAV1	3 (3%)	95	0.68981	1	0.71714	1	0.23439	1	NA	NA	0.69893	1	NA	NA	1	1	0.35419	1
ACTB	3 (3%)	95	NA	NA	0.18368	1	0.54936	1	NA	NA	1	1	NA	NA	0.067539	1	0.45404	1
CD86	3 (3%)	95	0.74319	1	0.54451	1	0.23439	1	NA	NA	1	1	NA	NA	NA	NA	1	1
SFRS2IP	5 (5%)	93	0.23281	1	0.11981	1	0.65012	1	NA	NA	0.10535	1	1	1	0.084687	1	0.32401	1